Cytophenix

Perth, Australia

Cytophenix is developing rapid antimicrobial susceptibility tests to identify the most effective antibiotics.

$855K raised

Oct 2025

Pre-Seed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Cytophenix raised?

Cytophenix has raised $855K in total funding. The most recent round was Pre-Seed. The last funding was announced in October 2025.

Who are Cytophenix's investors?

Cytophenix's investors include CSIRO, CUREator.

Where is Cytophenix headquartered?

Cytophenix is headquartered in Perth, Australia.

What does Cytophenix do?

Cytophenix is developing rapid antimicrobial susceptibility tests to identify the most effective antibiotics.

What stage is Cytophenix at?

Cytophenix is at the Pre-Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 29, 2025.

MLA

"Cytophenix — Funding & Investors." VCBacked, October 29, 2025, https://www.vcbacked.co/company/cytophenix. Accessed July 2, 2026.

APA

VCBacked. (2025). Cytophenix — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/cytophenix

Wikipedia (cite web)

{{cite web |title=Cytophenix — Funding & Investors |url=https://www.vcbacked.co/company/cytophenix |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 29, 2025.